Pooja Toshniwal Paharia

Pooja Toshniwal Paharia

M.D.S (OMR) - Masters in Dental Surgery (Oral Medicine and Radiology)

Oral Medicine, Radiology

Pooja Toshniwal Paharia is an oral and maxillofacial physician and radiologist based in Pune, India. Her academic background is in Oral Medicine and Radiology. She has extensive experience in research and evidence-based clinical-radiological diagnosis and management of oral lesions and conditions and associated maxillofacial disorders. Her expertise involves diagnosing and managing potentially malignant as well as malignant lesions and conditions, temporomandibular joint disorders, orofacial pain conditions, salivary gland disorders, developmental anomalies, dental management of systemic conditions and medical emergencies, etc. using conservative treatments inclusive of medications, physiotherapy, biofeedback coupled gold standards such as surgical excisions and advanced techniques such as low-level laser therapy and transcutaneous electric nerve stimulation.

See more

During her post-graduation, she received accolades at several national and international conferences for her scientific research papers and the Academic Excellence Award for two consecutive years at her educational institute. Her field of interest has always been the use of advanced and non-invasive novel diagnostic as well as therapeutic techniques for maxillofacial disorders to provide an improved standard of care to patients. She has worked extensively on several research projects based on molecular spectroscopic analysis of proteins and nucleic acids and radiological assessment of morphological alterations correlated with disease severity in potentially malignant conditions. She has also worked on systematic reviews on the immunological management of Sjogren’s syndrome using novel monoclonal antibodies. As part of her post-graduation curriculum, she has undertaken several scientific writing assignments based on weekly reviews of constantly updated scientific literature published in peer-reviewed medical journals.

She is currently working as a consultant oral and maxillofacial radiologist at an advanced dental diagnostic center in India and provides three-dimensional and accurate radiological diagnostic information to doctors and patients on several dental conditions. Pooja is passionate about writing and dental health. Outside of work, she enjoys art, music, traveling, reading, and cooking.

See less

Articles from Pooja Toshniwal Paharia

What makes some humans mosquito magnets?

What makes some humans mosquito magnets?

Effects of SARS-CoV-2-associated stress among pregnant women on development of fetus brain

Effects of SARS-CoV-2-associated stress among pregnant women on development of fetus brain

How COVID-19 impacted sleep and mental health among university students

How COVID-19 impacted sleep and mental health among university students

An estimated 15% of U.S. adults infected with SARS-CoV-2 have long-COVID

An estimated 15% of U.S. adults infected with SARS-CoV-2 have long-COVID

The impact of seasonal coronavirus immunity on susceptibility to SARS-CoV-2 infection and  COVID-19 vaccination

The impact of seasonal coronavirus immunity on susceptibility to SARS-CoV-2 infection and COVID-19 vaccination

What are the contemporary hazards of cigarette smoking and benefits of quitting smoking by race, ethnicity, and sex among US adults?

What are the contemporary hazards of cigarette smoking and benefits of quitting smoking by race, ethnicity, and sex among US adults?

Association of COVID-19 severity with nasopharyngeal fungal colonization and interleukin-17 induction

Association of COVID-19 severity with nasopharyngeal fungal colonization and interleukin-17 induction

Low-density granulocytes are phenotypically altered in people with long-COVID

Low-density granulocytes are phenotypically altered in people with long-COVID

Combination of multi-specificity and antibody avidity enhances protection against SARS-CoV-2

Combination of multi-specificity and antibody avidity enhances protection against SARS-CoV-2

The effectiveness of BNT162b2 COVID-19 vaccine against infection with SARS-CoV-2 Omicron subvariants BA.4/5

The effectiveness of BNT162b2 COVID-19 vaccine against infection with SARS-CoV-2 Omicron subvariants BA.4/5

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.